BELLUS Health Inc. (NASDAQ:BLU – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 7,590,000 shares, an increase of 6.2% from the May 15th total of 7,150,000 shares. Based on an average daily volume of 4,610,000 shares, the […]
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 7,590,000 shares, an increase of 6.2% from the May 15th total of 7,150,000 shares. Based on an average daily volume of 4,610,000 shares, the short-interest ratio is […]
BELLUS Health Inc. (TSE:BLU – Get Rating) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$18.14 and traded as high as C$19.38. BELLUS Health shares last traded at C$19.23, with a volume of 14,284 shares changing hands. Analyst Ratings Changes Separately, Lifesci Capital […]
The US$14.75-a-share deal, which goes to the Quebec Superior Court next week for approval, is the latest in a series of US$1-billion-plus takeovers of Canadian life sciences companies